{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:42:27Z","timestamp":1794278547878,"version":"4.9.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jaccao.2024.07.018","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:43:44Z","timestamp":1726613024000},"page":"699-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prognosis After Withdrawal of Cardioprotective Therapy in Patients With Improved Cancer Therapeutics\u2013Related Cardiac Dysfunction"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6832-9716","authenticated-orcid":false,"given":"Hyukjin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Geon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga Hui","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ju","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kye Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngkeun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2024.07.018_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","article-title":"Evaluation and management of patients with heart disease and cancer: cardio-oncology","volume":"89","author":"Herrmann","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaccao.2024.07.018_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaccao.2024.07.018_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2024.07.018_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/echo.14622","article-title":"Speckle tracking echocardiography in the early detection and prediction of anthracycline cardiotoxicity in diffuse large B-cell lymphoma treated with (R)-CHOP regimen","volume":"37","author":"Wang","year":"2020","journal-title":"Echocardiography"},{"key":"10.1016\/j.jaccao.2024.07.018_bib5","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehy453","article-title":"Cardio-oncology services: rationale, organization, and implementation","volume":"40","author":"Lancellotti","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2024.07.018_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11764-019-00795-5","article-title":"Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group","volume":"13","author":"Michel","year":"2019","journal-title":"J\u00a0Cancer Surviv"},{"key":"10.1016\/j.jaccao.2024.07.018_bib7","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the international late effects of childhood cancer guideline harmonization group","volume":"16","author":"Armenian","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaccao.2024.07.018_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.seminoncol.2013.01.005","article-title":"Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance","volume":"40","author":"Carver","year":"2013","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaccao.2024.07.018_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2024.07.018_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated\u00a0cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2024.07.018_bib11","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2024.07.018_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jaccao.2024.07.018_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.jaccao.2024.07.018_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.echo.2011.02.004","article-title":"Left atrial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction","volume":"24","author":"Morris","year":"2011","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jaccao.2024.07.018_bib15","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.jacc.2012.06.062","article-title":"Myocardial recovery and the failing heart: myth, magic, or molecular target?","volume":"60","author":"Mann","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2024.07.018_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCHEARTFAILURE.110.959684","article-title":"Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects","volume":"4","author":"Ambardekar","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jaccao.2024.07.018_bib17","doi-asserted-by":"crossref","first-page":"I229","DOI":"10.1161\/hc37t1.094914","article-title":"Normalized diastolic properties after left ventricular assist result from reverse remodeling of chamber geometry","volume":"104","author":"Barbone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2024.07.018_bib18","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa053063","article-title":"Left ventricular assist device and drug therapy for the reversal of heart failure","volume":"355","author":"Birks","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2024.07.018_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/eurheartj\/ehl365","article-title":"Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy","volume":"28","author":"Hall","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2024.07.018_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaccao.2024.01.009","article-title":"Withdrawal of neurohormonal antagonists in breast cancer patients with cardiotoxicity and improved left ventricular function","volume":"6","author":"Yu","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2024.07.018_bib21","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S0828-282X(09)70497-0","article-title":"Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy","volume":"25","author":"Moon","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jaccao.2024.07.018_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ahj.2006.02.008","article-title":"Improved outcomes in peripartum cardiomyopathy with contemporary","volume":"152","author":"Amos","year":"2006","journal-title":"Am Heart J"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087324002783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087324002783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T17:21:25Z","timestamp":1733332885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087324002783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2666087324002783"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2024.07.018","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosis After Withdrawal of Cardioprotective Therapy in Patients With Improved Cancer Therapeutics\u2013Related Cardiac Dysfunction","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2024.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}